Latest Biotechnology, Pharmaceutical and Healthcare News from PharmaBiz
Here are the most relevant search results for "PharmaBiz" found in our extensive news archives from over 250 global news sources.
More Information about PharmaBiz on BioPortfolio
In addition to our news stories we have dozens of PubMed Articles about PharmaBiz for you to read. Along with our medical data and news we also list PharmaBiz Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaBiz Companies for you to search.
Showing News Articles 1–25 of 248 from PharmaBiz
Researchers identify risk markers for ED following radiation treatment in prostate cancer
A research team led by Albert Einstein College of Medicine of Yeshiva University and Mount Sinai School of Medicine discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treate...
Bangla pharma industry raring to scale higher peaks
Pharmaceutical industry, one of the most dynamic and powerful sectors in Bangladesh, is technologically the most developed manufacturing industries and is the second─largest contributor to the government exchequer. The industry contributes about...
Neuralstem receives approval to begin ischemic stroke clinical trial in China
Neuralstem, Inc. has received approval to commence a clinical trial to treat motor deficits due to ischemic stroke with its spinal cord stem cells (NSI─566) at BaYi Brain Hospital, in Beijing, China, through its subsidiary, Neuralstem China (Suzhou...
Pharma industry need to look sustaining growth post 2015 when patent expiries stop
Baring Private Equity Partners India perceives that India pharma will now need to look at sustaining its growth momentum post 2015 when there will be no major drugs going off patent.
Periodic Analysis of Exports of Drugs, Pharmaceuticals & Fine Chemicals (Apr10─Dec10 visa─Vis Apr11─Dec 11)
BANNED DRUGS IN INDIA update
IISc's Dr G Mugesh wins Shanti Swarup Bhatnagar award for contributions in scientific research
Dr Govindasamy Mugesh, Associate Professor, Department of Inorganic & Physical Chemistry, Indian Institute of Science (IISc), Bengaluru has bagged the 2012 Shanti Swarup Bhatnagar award for his contributions in scientific research.
After several years of debates and discussions, the Group of Ministers (GoM) has finally approved the national pharmaceutical pricing policy to control the prices of all 348 essential drugs and adopted the weighted average price mechanism to cap the...
ABLE advocates regulatory revamp, calls for single window and evidence─based approvals
Association of Biotechnology Led Entrepreneurs (ABLE) has now proposed to the Union government for an overhaul of the current biotechnology regulatory process.
Right to info on medicines ─ need for new regulations
The Drugs & Magic Remedies (Objectionable Advertisements) Act (DMRA) 1954 and Rules were enacted way back in the 1950s when the field of medical science and pharmaceutical sciences had not developed as of today in India.
The Spurious Drugs Act came into effect from August 2009 with the objective of eliminating the menace of manufacturing and sales of spurious drugs in the country.
Molecular Insight begins phase II trial of 99mTc─MIP─140, a prostate cancer molecular imaging agent
Molecular Insight Pharmaceuticals, Inc., a clinical─stage biopharmaceutical company, has initiated phase II clinical trial of prostate cancer molecular imaging agent, 99mTc─MIP─1404.
Lily White Health advocates 'shared clinical practice' to offset doctor distribution imbalance
Lily White Health Consortium Pvt. Ltd., a hospital management and consulting firm, views that the Indian healthcare industry will need to adopt the concept of shared clinical practice to offset the imbalance in the distribution of medical expertise.
NextBio, Emory University partner to identify biomarkers and treatments for cancer patients
NextBio, a provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, has collaborated with Emory University and its Winship Cancer Institute
The Karnataka government will extend all possible assistance for the growth of the biotechnology industry infrastructure and manpower development, said Subir Hari Singh, Additional Chief Secretary, Government of Karnataka.
NPPA notification dated September 19, 2012 fixing/revising the prices in respect of 33 formulation packs
Novo Nordisk invests US$ 100 mn to expand its R&D facility in China
Novo Nordisk, a global healthcare company with 89 years of innovation and leadership in diabetes care, has reaffirmed its long─term commitment to China by investing an additional 100 million US dollars to expand its state─of─the─art science f...
Kelly Services India sees major growth in pharma recruitment business
Kelly Services India, a workforce solutions major sees pharma recruitment business as a growth engine for itself. Going by the generic drug opportunity, the Indian pharma companies have already put in plans to beef up their hiring in the sales and ma...
DKSH, Astellas extend partnership agreement for medical products distribution in Taiwan
DKSH, the leading Market Expansion Services Group with focus on Asia, and Astellas, a Japanese pharmaceutical company focusing on primary care treatments, have signed an agreement extending their partnership for medical products distribution in Taiwa...
Students at Govt Siddha Medical College in TN approach state govt with a barrage of complaints
Fearing that the poor condition of the college will affect its affiliation with Central Council of Indian Medicine (CCIM), the Post Graduate Students Association at the Government Siddha Medical College at Palayamkottai in Thirunelveli district in Ta...
Galleon announces positive second phase I study results of GAL─021 to treat respiratory depression
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing control disorders, has reported positive results from a second phase I clinical study of its investigational drug GAL─021 confirmed previous findings that th...
Amgen, a biotech company discovers, develops, manufactures and delivers innovative human therapeutics has received the US Food and Drug Administration (FDA) approval for new indication for Prolia (denosumab) as a treatment to increase bone mass in me...
NIPER to hold seminar for SMPEs on 'environment & waste management' on Sept 29
The National Institute of Pharmaceutical Education and Research (NIPER), which provides the technical support to small and medium pharma enterprises (SMPEs), is planning to organise a seminar on Environment, Hazard and Waste Management on September...
NPPA notification dated July 19, 2012 fixing/revising the prices in respect of 154 formulation packs
NPPA notification dated July 19, 2012 fixing/revising the prices in respect of 154 formulation packs
Meet on geriology, geriatric medicine & rehabilitation to be held in Bengaluru on Sept 29
The first international conference on Geriology, Geriatric Medicine and Rehabilitation titled 'Healthy Ageing in the Changing World 2012' will be held on September 29, at the JN Tata Auditorium in Bengaluru.
